In contrast, neither somatic mutations [8] nor epigenetic silencing of BRCA1 transcription by promoter methylation [6, 9–12] can fully explain the low level of BRCA1 expression frequently associated with the onset and/or progression of sporadic breast cancer, the most frequent form of the disease [13–17]. Here, BRCA1 is linked to breast carcinoma.